[Skip to Content]
[Skip to Content Landing]
August 24/31, 2005

Primary Prophylaxis With the Implantable Cardioverter-DefibrillatorThe Need for Improved Risk Stratification

Author Affiliations

Author Affiliations: The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY.

JAMA. 2005;294(8):958-960. doi:10.1001/jama.294.8.958

Identification of patients at risk for sudden cardiac death (SCD) is a major challenge for the medical community. Although there have been advances in the area of risk stratification, it remains troubling that the majority of individuals who die of SCD are among a population that is not identified by current methods of risk stratification.1 Nevertheless, several recent trials have attempted to identify groups of patients who may benefit from an implantable cardioverter-defibrillator (ICD).

First Page Preview View Large
First page PDF preview
First page PDF preview